dihexa human clinical trials published DIHEXA Capsules — Peptech Dihexa (PNB-0408) | c-Met/HGFR Activator

In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose

Long-term smoking not only elevates the risk of lung cancer but is also closely associated with the incidence of hypertension

In the Ras pathway, Erk1/2 as two mitogen-activated protein kinases to transmit mitotic signals, and the HGF/c-Met signaling pathway phosphorylates and activates Erk1/2 after PHx (Spector et al., 1997

Injections are administered subcutaneously, typically in abdominal fat or other convenient sites

Tosin, who has more than two decades of experience